Wendall Wierenga, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 5,000 shares at $74.09 ($370K) on 2012-08-24, disclosed to the SEC on 2012-08-28.
Open-market sale of $370k ONXX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2024-11-26 | $37K | — | Filing → |
| CYTK | SELL | 2024-10-31 | $233K | — | Filing → |
| CYTK | SELL | 2023-12-27 | $368K | — | Filing → |